Sees Q2 Revenue of $355M-$365M
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 day ago
0mins
Should l Buy ALAB?
Sees Q2 revenue $355M-$365M, consensus $310.06M. Sees Q2 gross margin 73%.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ALAB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ALAB
Wall Street analysts forecast ALAB stock price to fall
19 Analyst Rating
14 Buy
5 Hold
0 Sell
Moderate Buy
Current: 213.910
Low
155.00
Averages
206.18
High
250.00
Current: 213.910
Low
155.00
Averages
206.18
High
250.00
About ALAB
Astera Labs, Inc. is a global semiconductor company. The Company provides semiconductor-based connectivity solutions for cloud and artificial intelligence (AI) infrastructure. It has developed and deployed its Intelligent Connectivity Platform built from the ground up for cloud and AI infrastructure. Its Intelligent Connectivity Platform provides its customers with the ability to deploy and operate high-performance cloud and AI infrastructure at scale, addressing an increasingly diverse set of requirements. It provides its connectivity products in various form factors, including Integrated Circuits (ICs), boards, and modules. Its PCIe, CXL and Ethernet semiconductor-based connectivity solutions are purpose-built to unleash the potential of accelerated computing at cloud-scale. The Company’s products include Aries products, which include its COSMOS software suite; Taurus products, which are hardware modules based on its Taurus ICs; Leo products; and Scorpio products.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Astera Labs Q1 2026 Earnings Exceed Expectations
- Significant Revenue Growth: Astera Labs reported Q1 revenue of $308 million, representing a 14% increase from the previous quarter and a remarkable 93% year-over-year growth, highlighting the company's strong performance amid accelerating AI infrastructure spending and solidifying its market position.
- Product Line Expansion: The company announced the expansion of its Scorpio product line, with initial shipments of the 320-lane Scorpio X, expected to ramp up production volumes in the second half of 2026, enhancing its competitiveness in the high-performance computing market.
- Improved Profitability: The first quarter non-GAAP gross margin was 76.4% and operating margin was 36.2%, demonstrating success in cost control and efficiency improvements, with an expected gross margin of approximately 73% for Q2 despite a non-cash impact from a customer agreement.
- Optimistic Future Outlook: The company expects Q2 revenue to be between $355 million and $365 million, with non-GAAP EPS projected between $0.68 and $0.70, reflecting management's confidence in sustained growth, particularly driven by the Scorpio product line.
See More
ASTERA LABS, INC.: BARCLAYS INCREASES TARGET PRICE FROM $165 TO $200
Company Overview: Aster Labs, Inc. is a company that has recently been analyzed by Barclays.
Target Price Increase: Barclays has raised the target price for Aster Labs from $165 to $200.
See More
Astera Labs Q1 Results Drive 7% Stock Surge Amid Analyst Upgrades
- Strong Earnings Beat: Astera Labs reported Q1 revenue of $360 million, exceeding market expectations of $310 million by 17%, driven by robust demand for AI infrastructure, which solidifies its market position.
- Analyst Upgrades: J.P. Morgan raised Astera's price target from $205 to $280, reflecting confidence in the continued growth of the Scorpio product line, while Jefferies and other firms also increased their targets, indicating optimistic market sentiment about future performance.
- Product Line Expansion: Strong shipments of the Scorpio “P” series and Taurus product lines have propelled revenue growth, with expectations for a significant ramp-up of the Scorpio X series in the second half of 2026, further enhancing the company's competitive edge.
- Margin Pressure: Despite strong performance, analysts anticipate a decline in gross margins by 200-300 basis points in the second half of the year due to unfavorable SKU mix within the Scorpio X product line and a higher proportion of hardware sales, which may pose short-term profitability challenges.
See More
Futures Rise as Trump Pauses Hormuz Opening Efforts
- Futures Market Surge: Futures prices have risen, reflecting optimistic sentiment regarding future economic prospects, which may attract more investors and drive overall market recovery.
- Trump's Policy Shift: President Trump announced a pause on the Hormuz opening efforts, a move that could significantly impact global energy supply chains and the stability of oil markets.
- AI Company Earnings Impact: Companies like AMD, Astera Labs, Lumentum, and Arista became market movers following their earnings reports, highlighting the strong growth potential in the AI sector and possibly drawing more investor interest towards these tech stocks.
- Market Dynamics Fluctuation: With the changes in Trump's policies and the earnings impact from AI companies, market sentiment may experience volatility, prompting investors to closely monitor developments to adjust their investment strategies.
See More
Markets Hit New Highs, AI Infrastructure Leads the Charge
- Market Performance: On Tuesday, markets continued to rise without new escalations in the Middle East conflict, with West Texas Intermediate crude down about 4% and the benchmark 10-year Treasury yield slightly lower, indicating increased investor confidence in the market.
- Tech Stocks Lead: Chipmakers like Intel, SanDisk, and Micron saw double-digit percentage gains, driving a strong overall performance for technology stocks, with Amazon, Broadcom, Alphabet, and Qnity hitting new 52-week highs, reflecting robust performance in AI-related stocks.
- Strong Earnings Boost Materials: The materials sector emerged as the top performer in the S&P 500, with DuPont being the biggest mover due to its strong earnings report, highlighting investor confidence and interest in the materials industry.
- Robotic Surgery System Progress: Johnson & Johnson announced that its Ottava robotic surgery system achieved primary endpoints in clinical studies for Roux-en-Y gastric bypass procedures, which is expected to support FDA approval for multiple upper abdominal surgeries, further solidifying its position in the robotic surgery market.
See More
Astera Labs Set to Announce Q1 Earnings on May 5th
- Earnings Announcement: Astera Labs (ALAB) is set to release its Q1 earnings on May 5th after market close, with a consensus EPS estimate of $0.54, reflecting a significant year-over-year increase of 63.6%, which could further solidify its positive market image.
- Strong Revenue Expectations: The anticipated revenue for Q1 is $292.32 million, representing an impressive year-over-year growth of 83.4%, indicating the company's robust performance in the rapidly expanding AI market, potentially attracting more investor interest.
- Outstanding Historical Performance: Over the past two years, Astera Labs has beaten EPS and revenue estimates 100% of the time, and this consistent outperformance not only boosts market confidence but also lays a solid foundation for future growth.
- Revision Trends: In the last three months, EPS estimates have seen 13 upward revisions and 6 downward, while revenue estimates have experienced 16 upward revisions with no downward adjustments, reflecting analysts' optimistic outlook on Astera Labs' future performance, which may drive stock price increases.
See More
Astera Labs Q1 2026 Earnings Exceed Expectations
- Significant Revenue Growth: Astera Labs reported Q1 revenue of $308 million, representing a 14% increase from the previous quarter and a remarkable 93% year-over-year growth, highlighting the company's strong performance amid accelerating AI infrastructure spending and solidifying its market position.
- Product Line Expansion: The company announced the expansion of its Scorpio product line, with initial shipments of the 320-lane Scorpio X, expected to ramp up production volumes in the second half of 2026, enhancing its competitiveness in the high-performance computing market.
- Improved Profitability: The first quarter non-GAAP gross margin was 76.4% and operating margin was 36.2%, demonstrating success in cost control and efficiency improvements, with an expected gross margin of approximately 73% for Q2 despite a non-cash impact from a customer agreement.
- Optimistic Future Outlook: The company expects Q2 revenue to be between $355 million and $365 million, with non-GAAP EPS projected between $0.68 and $0.70, reflecting management's confidence in sustained growth, particularly driven by the Scorpio product line.
See More
ASTERA LABS, INC.: BARCLAYS INCREASES TARGET PRICE FROM $165 TO $200
Company Overview: Aster Labs, Inc. is a company that has recently been analyzed by Barclays.
Target Price Increase: Barclays has raised the target price for Aster Labs from $165 to $200.
See More
Astera Labs Q1 Results Drive 7% Stock Surge Amid Analyst Upgrades
- Strong Earnings Beat: Astera Labs reported Q1 revenue of $360 million, exceeding market expectations of $310 million by 17%, driven by robust demand for AI infrastructure, which solidifies its market position.
- Analyst Upgrades: J.P. Morgan raised Astera's price target from $205 to $280, reflecting confidence in the continued growth of the Scorpio product line, while Jefferies and other firms also increased their targets, indicating optimistic market sentiment about future performance.
- Product Line Expansion: Strong shipments of the Scorpio “P” series and Taurus product lines have propelled revenue growth, with expectations for a significant ramp-up of the Scorpio X series in the second half of 2026, further enhancing the company's competitive edge.
- Margin Pressure: Despite strong performance, analysts anticipate a decline in gross margins by 200-300 basis points in the second half of the year due to unfavorable SKU mix within the Scorpio X product line and a higher proportion of hardware sales, which may pose short-term profitability challenges.
See More
Futures Rise as Trump Pauses Hormuz Opening Efforts
- Futures Market Surge: Futures prices have risen, reflecting optimistic sentiment regarding future economic prospects, which may attract more investors and drive overall market recovery.
- Trump's Policy Shift: President Trump announced a pause on the Hormuz opening efforts, a move that could significantly impact global energy supply chains and the stability of oil markets.
- AI Company Earnings Impact: Companies like AMD, Astera Labs, Lumentum, and Arista became market movers following their earnings reports, highlighting the strong growth potential in the AI sector and possibly drawing more investor interest towards these tech stocks.
- Market Dynamics Fluctuation: With the changes in Trump's policies and the earnings impact from AI companies, market sentiment may experience volatility, prompting investors to closely monitor developments to adjust their investment strategies.
See More
Markets Hit New Highs, AI Infrastructure Leads the Charge
- Market Performance: On Tuesday, markets continued to rise without new escalations in the Middle East conflict, with West Texas Intermediate crude down about 4% and the benchmark 10-year Treasury yield slightly lower, indicating increased investor confidence in the market.
- Tech Stocks Lead: Chipmakers like Intel, SanDisk, and Micron saw double-digit percentage gains, driving a strong overall performance for technology stocks, with Amazon, Broadcom, Alphabet, and Qnity hitting new 52-week highs, reflecting robust performance in AI-related stocks.
- Strong Earnings Boost Materials: The materials sector emerged as the top performer in the S&P 500, with DuPont being the biggest mover due to its strong earnings report, highlighting investor confidence and interest in the materials industry.
- Robotic Surgery System Progress: Johnson & Johnson announced that its Ottava robotic surgery system achieved primary endpoints in clinical studies for Roux-en-Y gastric bypass procedures, which is expected to support FDA approval for multiple upper abdominal surgeries, further solidifying its position in the robotic surgery market.
See More
Astera Labs Set to Announce Q1 Earnings on May 5th
- Earnings Announcement: Astera Labs (ALAB) is set to release its Q1 earnings on May 5th after market close, with a consensus EPS estimate of $0.54, reflecting a significant year-over-year increase of 63.6%, which could further solidify its positive market image.
- Strong Revenue Expectations: The anticipated revenue for Q1 is $292.32 million, representing an impressive year-over-year growth of 83.4%, indicating the company's robust performance in the rapidly expanding AI market, potentially attracting more investor interest.
- Outstanding Historical Performance: Over the past two years, Astera Labs has beaten EPS and revenue estimates 100% of the time, and this consistent outperformance not only boosts market confidence but also lays a solid foundation for future growth.
- Revision Trends: In the last three months, EPS estimates have seen 13 upward revisions and 6 downward, while revenue estimates have experienced 16 upward revisions with no downward adjustments, reflecting analysts' optimistic outlook on Astera Labs' future performance, which may drive stock price increases.
See More
